Aralast® NP

Understanding Aralast® NP

Aralast® NP is a medication used to treat alpha-1 antitrypsin deficiency (AATD), a genetic disorder that can lead to chronic obstructive pulmonary disease (COPD) and emphysema due to low levels of alpha-1 antitrypsin (AAT)—a protein that protects the lungs from damage.

How Aralast® NP Works:

• Replaces missing AAT, helping protect the lungs from further damage
• Slows the progression of lung disease in patients with AATD
• Reduces lung inflammation, lowering the risk of COPD-related complications

FDA Approval:

• Aralast® NP: Approved in 2002

For more information, please visit the Aralast® NP patient website and speak with your healthcare provider to determine if Aralast® NP is the right treatment option for you.